Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +55.52%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +28.33%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +25.08%
#7 Enso Enso +18.12%
#8 Velvet Velvet +16.00%
#9 Tutorial Tutorial +15.35%
#10 OVERTAKE OVERTAKE +15.31%
Coin of the day
EXOD EXOD
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Ortin Laboratories Limited Ortin Laboratories Limited

Ortin Laboratories Limited

ORTINLAB
Peringkat dalam Saham #37115
Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad,... Ortin Laboratories Limited, a pharmaceutical company established in Hyderabad, India, in 1986, is engaged in the manufacturing and commercialization of a diverse range of medicines, drugs, and chemical intermediates. The company provides a wide array of pharmaceutical formulations, presented as tablets, capsules, syrups, and dry powders. These products target various therapeutic domains such as metabolic diseases (e.g., anti-diabetics), allergic reactions, infections (including broad-spectrum antibiotics and antifungals like quinolones, penicillins, cephalosporins, macrolides, and antifungals), pain management and fever reduction (analgesics and antipyretics), cardiovascular ailments (anti-anginal and cardiovascular products), digestive system disorders (antacids and anti-ulcerants), neurological and psychiatric conditions (sedatives, tranquilizers, psychiatry products), and nutritional supplementation (like vitamins, calcium, iron, and protein supplements). Specialized offerings also include anti-retroviral, anti-arthritic, anti-helminthic, anti-spasmodic, gynaec, appetite stimulators, and chemotherapeutic preparations. In addition to finished pharmaceuticals, Ortin produces active pharmaceutical ingredient (API) intermediates for applications such as anti-retrovirals, anti-diabetics, pain and fever medications, antibiotics, antifungals, antacids, anti-malarials, and anti-ulcerants. Its manufacturing capabilities also extend to fine chemicals and Grignard/alkali metal compounds. The company offers specialized services covering process development and characterization, analytical research, assay development, and product characterization. It also contributes to diagnostics through the development of rapid flow kits, assays, and reagents. Ortin Laboratories undertakes long-term contracts for the production of intermediates and the creation of novel APIs. Moreover, it actively functions as a merchant exporter of its finished pharmaceutical products.
Harga Saham
$0.2488447
Terakhir disinkronkan: 2024-10-01
Kapitalisasi Pasar
$2.01M
Perubahan (1 hari)
-1.88%
Perubahan (1 tahun)
0.00%
Negara
IN
Perdagangan Ortin Laboratories Limited (ORTINLAB)

Kategori

Healthcare
Pendapatan untuk Ortin Laboratories Limited (ORTINLAB)
Pendapatan pada Jun 2024 TTM: $89.95K
Menurut laporan keuangan terbaru dari Ortin Laboratories Limited, pendapatan saat ini (TTM) adalah $89.95K. Pada tahun 2023, perusahaan menghasilkan pendapatan sebesar $732.57K penurunan dibandingkan dengan pendapatan pada tahun 2022 yang sebesar $1.08M. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Ortin Laboratories Limited dari 2008 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Mengubah
2026 (TTM) $89.95K -64.48%
2024 $253.23K -65.43%
2023 $732.57K -32.44%
2022 $1.08M -2.82%
2021 $1.12M -95.72%
2020 $26.04M 10.75%
2019 $23.51M 92.06%
2018 $12.24M 87.73%
2017 $6.52M 8.62%
2016 $6.00M -4.55%
2015 $6.29M -33.47%
2014 $9.45M -12.98%
2013 $10.86M -35.79%
2012 $16.92M 20.37%
2011 $14.06M 101.43%
2010 $6.98M 19.15%
2009 $5.86M -19.40%
2008 $7.27M 0.00%
Pendapatan untuk perusahaan serupa atau pesaing
Perusahaan Pendapatan Perbedaan Pendapatan Negara
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B 7,349,893.64%
IN